Valerie Treyer Selected Research

Metabotropic Glutamate 5 Receptor

7/2020	The role of the metabotropic glutamate receptor 5 in nicotine addiction.
1/2020	Metabotropic glutamate receptor 5 in bulimia nervosa.
10/2018	Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder.
1/2018	A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5.
1/2017	Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
12/2014	Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder.
1/2013	Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
7/2011	Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valerie Treyer Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2014
5	Neoplasms (Cancer) 01/2022 - 04/2007
4	Cognitive Dysfunction 01/2022 - 01/2018
4	Tobacco Use Disorder (Nicotine Dependence) 07/2020 - 01/2013
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 04/2003
4	Glioma (Gliomas) 07/2007 - 06/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2010
3	Dementia (Dementias) 01/2022 - 01/2020
3	Inflammation (Inflammations) 01/2021 - 09/2019
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2020 - 06/2019
2	Atrophy 01/2022 - 01/2018
2	Brain Neoplasms (Brain Tumor) 02/2020 - 04/2007
1	Lymphadenopathy 01/2022
1	COVID-19 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Lung Diseases (Lung Disease) 03/2021
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Ischemia 07/2020
1	Cicatrix (Scar) 07/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020
1	Bulimia Nervosa 01/2020
1	Cardiomyopathies (Cardiomyopathy) 09/2019
1	Pathologic Processes 01/2019
1	Death (Near-Death Experience) 10/2018
1	Myocardial Infarction 10/2018
1	Alcoholism (Alcohol Abuse) 10/2018
1	Amyloid Plaque 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2017
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2014
1	Mental Disorders (Mental Disorder) 02/2012
1	Major Depressive Disorder (Major Depressive Disorders) 07/2011
1	Renal Insufficiency (Renal Failure) 01/2011
1	Breast Neoplasms (Breast Cancer) 10/2010
1	Esophageal Neoplasms (Esophageal Cancer) 10/2010
1	Duodenal Neoplasms (Duodenal Cancer) 10/2010
1	Liver Neoplasms (Liver Cancer) 10/2010
1	Neoplasm Metastasis (Metastasis) 10/2010
1	Stomach Neoplasms (Stomach Cancer) 10/2010
1	Anus Neoplasms (Anal Cancer) 10/2010
1	Necrosis 07/2006
1	Gambling (Pathological Gambling) 06/2006

Drug/Important Bio-Agent (IBA)

8	Metabotropic Glutamate 5 ReceptorIBA 07/2020 - 07/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2016
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2017
4	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 04/2010
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2021 - 04/2007
3	Nicotine FDA Link 07/2020 - 01/2013
3	technetium tc-99m tetrofosmin (Myoview)FDA Link 01/2020 - 04/2010
3	Amyloid beta-PeptidesIBA 01/2018 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2018
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 07/2020
2	Apolipoprotein E4IBA 01/2020 - 01/2020
2	IronIBA 01/2020 - 01/2018
2	ApolipoproteinsIBA 01/2020 - 01/2020
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 10/2018
2	Fibronectins (Fibronectin)IBA 04/2007 - 07/2006
2	fluorocholineIBA 04/2007 - 06/2006
2	Acetazolamide (Diamox)FDA LinkGeneric 08/2004 - 04/2003
1	VaccinesIBA 01/2022
1	flutemetamolIBA 01/2022
1	LipidsIBA 04/2021
1	Neuroprotective AgentsIBA 04/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2021
1	CalciumIBA 01/2021
1	gallium Ga 68 dotatateIBA 01/2021
1	Folate Receptor 1IBA 04/2020
1	Immune Checkpoint InhibitorsIBA 02/2020
1	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 05/2019
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 10/2018
1	GTP-Binding Proteins (G-Protein)IBA 10/2018
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2018
1	Inositol (Myoinositol)IBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 02/2012
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2011
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2010
1	Amino Acids FDA Link 07/2007
1	GadoliniumIBA 07/2007
1	SIP(L19) fusion proteinIBA 04/2007
1	Infliximab (Remicade)FDA Link 07/2006

Therapy/Procedure

3	Therapeutics 07/2020 - 10/2010
1	Activities of Daily Living (ADL) 01/2021
1	Immunotherapy 02/2020
1	Radiotherapy 02/2020
1	Self Administration (Administration, Self) 01/2013
1	CT protocol 10/2010
1	Drug Therapy (Chemotherapy) 07/2007
1	Intravenous Injections 04/2007
1	Radioimmunotherapy 07/2006
1	Aftercare (After-Treatment) 07/2006
1	Transcranial Magnetic Stimulation 06/2006